About: Rapid Adaptation of Breast Radiotherapy Utilization during the COVID-19 Pandemic at a Large Academic Cancer Centre in Canada

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Rapid Adaptation of Breast Radiotherapy Utilization during the COVID-19 Pandemic at a Large Academic Cancer Centre in Canada Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Rapid Adaptation of Breast Radiotherapy Utilization during the COVID-19 Pandemic at a Large Academic Cancer Centre in Canada
Creator	Liu, Z Koch, C Lee, G Barry, A Croke, J Derocchis, J Ff, Liu Fyles, A Hahn, E Han, K Helou, J Isfahanian, N Liu Phd, Z Liu, F-F Liu, F.-F Lofgren, S Md, A Purdie, T Rodin, D
Source	Elsevier; Medline; PMC
abstract	BACKGROUND: Mitigation strategies to balance the risk of COVID-19 infection against oncologic risk in breast cancer patients undergoing radiotherapy have been deployed. To this end, shorter hypofractionated regimens have been recommended where appropriate, with prioritization of radiotherapy by oncologic risk and omission or deferral of radiotherapy for lower risk cases. Timely adoption of these measures reduces COVID-19 risk to both patients and health care workers, and preserves resources. Herein we present our early response and adaptation of breast radiotherapy utilization during the COVID-19 pandemic at a large academic cancer centre in Canada. METHODS: A state of emergency was announced in Ontario on March 17, 2020 due to the COVID-19 pandemic. Emergency guidelines were instituted. To examine our response, the number of weekly breast RT starts, type of breast RT, and patient age were compared from March 1 to April 30, 2020 to the same period in 2019. RESULTS: Following the declaration of emergency in Ontario, there was a decrease of 39% in radiotherapy starts in 2020 compared to 2019 (79 vs. 129, p<0.001). There was a relative increase in the proportion of patients receiving regional nodal irradiation (RNI) in 2020 compared to 2019 (46% vs. 29%, respectively), with the introduction of hypofractionated RNI in 2020 (27 of 54 cases, 50%). A smaller proportion of patients starting radiotherapy were aged > 50 years in 2020, 66% (78/118) vs. 83% (132/160) in 2019, p=0.0027. CONCLUSIONS: A significant reduction in breast radiotherapy starts was noted during the early response to the COVID-19 pandemic, with prioritization of radiotherapy to patients associated with higher oncologic risk requiring RNI. A quick response to a health care crisis is critical, and is of particular importance for higher volume cancer sites where the potential impact on resources is greater.
has issue date	2020-06-19(xsd:dateTime)
bibo:doi	10.1016/j.adro.2020.06.002
bibo:pmid	32775788
has license	no-cc
sha1sum (hex)	721ad84c7cf66a7a9ed7b9f364545c03cf1fe1ae
schema:url	https://doi.org/10.1016/j.adro.2020.06.002
resource representing a document's title	Rapid Adaptation of Breast Radiotherapy Utilization during the COVID-19 Pandemic at a Large Academic Cancer Centre in Canada
has PubMed Central identifier	PMC7303606
has PubMed identifier	32775788
schema:publication	Adv Radiat Oncol
resource representing a document's body	covid:721ad84c7cf66a7a9ed7b9f364545c03cf1fe1ae#body_text
is schema:about of	named entity 'Pandemic' named entity 'Radiation Oncology' named entity 'Rapid' named entity 'Centre' named entity 'Canada' named entity 'FAST-Forward' named entity 'statistical analyses' named entity 'comorbidities' named entity '0.21' named entity 'morbidity' named entity 'radiotherapy' named entity 'radiotherapy' named entity 'radiotherapy' named entity 'COVID' named entity 'radiotherapy' named entity 'radiotherapy' named entity 'multi-disciplinary' named entity 'radiotherapy' named entity 'infection' named entity 'cancer care' named entity 'radiotherapy' named entity 'adjuvant' named entity 'Breast cancer' named entity 'radiotherapy' named entity 'management of cancer' named entity 'breast cancer' named entity 'radiotherapy' named entity 'COVID' named entity 'radiotherapy' named entity 'physical distancing' named entity 'breast cancer' named entity 'endocrine therapy' named entity 'quality assurance' named entity 'radiotherapy' named entity 'Ontario' named entity 'comorbidities' named entity 'radiotherapy' named entity 'breast cancer' named entity 'health care' named entity 'oncologic' named entity 'COVID' named entity 'breast surgery' named entity 'radiotherapy' named entity 'HER2 negative' named entity 'breast cancer' named entity 'multi-disciplinary' named entity 'health care worker' named entity 'management decisions' named entity 'COVID' named entity 'oncologic' named entity 'older patients' named entity 'radiotherapy' named entity 'ER negative' named entity 'lymphovascular invasion' named entity 'Pearson's chi-square test' named entity 'COVID' named entity 'radiotherapy' named entity 'radiotherapy' named entity 'radiotherapy' named entity 'comorbidities' named entity 'oncologic' named entity 'radiation medicine' named entity 'COVID-19 pandemic'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software